migraines

New migraine drugs less effective than previous generation of triptan meds: BMJ study
Fierce Pharma
Thu, 09/19/24 - 09:29 pm
migraines
BMJ
Pfizer
Nurtec
AbbVie
Ubrelvy
Eli Lilly
Reyvow
Migraine market expected to reach $16.4bn across 7MM by 2033
Clinical Trials Arena
Sun, 09/8/24 - 11:29 pm
migraines
AbbVie's Ubrelvy wards off migraines when used in reaction to early warning signs: study
Fierce Pharma
Thu, 08/29/24 - 06:06 pm
AbbVie
Ubrelvy
migraines
clinical trials
Pfizer launches new website for migraine, respiratory offerings
Reuters
Tue, 08/27/24 - 10:57 am
Pfizer
migraines
Respiratory
website
After Europe deal, Organon pays $22.5M to expand Emgality marketing pact with Lilly
Fierce Pharma
Tue, 08/20/24 - 11:34 am
Organon
Europe
Eli Lilly
Emgality
Rayvow
migraines
Teva reports positive data from Phase III pediatric migraine prevention trial
Clinical Trials Arena
Fri, 07/19/24 - 11:42 am
Teva Pharmaceutical
pediatrics
migraines
Ajovy
clinical trials
ShiraTronics’ neuromodulation device reduces migraine frequency
Clinical Trials Arena
Wed, 07/17/24 - 09:13 pm
Medtech
ShiraTronics
migraines
neurostimulation
AbbVie Touts Long-Term Efficacy of Qulipta as Preventive Migraine Treatment
BioSpace
Mon, 04/15/24 - 11:06 am
AbbVie
clinical trials
migraines
Qulipta
Lady Gaga’s latest Nurtec ad is out and fans have something to say about it
Medical Marketing and Media
Sun, 04/14/24 - 01:25 pm
Pfizer
migraines
Nurtec
celebrity endorsements
Teva’s Ajovy hits endpoint in Chinese Phase III trial for migraine prevention
Clinical Trials Arena
Thu, 04/11/24 - 11:43 am
Teva Pharmaceutical
clinical trials
Ajovy
migraines
China
FDA declines to approve Shin Nippon Biomedical's migraine drug
Reuters
Thu, 01/18/24 - 11:05 am
FDA
Shin Nippon Biomedical
migraines
Organon pays $50M to pick up rights to pair of Eli Lilly migraine meds in Europe
Fierce Pharma
Mon, 12/18/23 - 10:16 pm
Organon
Eli Lilly
migraines
Europe
Teva’s Ajovy yields positive data in post-hoc migraine analysis
Clinical Trials Arena
Wed, 12/6/23 - 10:20 am
Teva Pharmaceutical
Ajovy
obesity
migraines
post-hoc analysis
Teva drops patent case against Lilly after two Ajovy patents deemed invalid
Fierce Pharma
Tue, 11/28/23 - 11:40 pm
Teva Pharmaceutical
legal
Eli Lilly
Ajovy
patents
migraines
AbbVie’s Migraine Drug Ubrelvy Scores Victory in Phase III Study
BioSpace
Fri, 11/17/23 - 10:00 am
AbbVie
Ubrelvy
ubrogepant
migraines
clinical trials
US judge overturns Eli Lilly's $176.5 million loss in Teva patent case
Reuters
Tue, 09/26/23 - 09:49 pm
Eli Lilly
Teva Pharmaceutical
migraines
Ajovy
Emgality
patents
legal
Salvia’s neuromodulation therapy for severe migraines shows promise
Clinical Trials Arena
Thu, 08/24/23 - 11:48 am
Salvia
Medtech
neuromodulation
migraines
Lilly’s Migraine Drug Emgality Fails to Outperform Pfizer’s Nurtec
BioSpace
Mon, 06/19/23 - 10:31 am
Eli Lilly
Emgality
Pfizer
Nurtec
migraines
NICE gives thumbs-up to Pfizer's migraine drug—but with lots of restrictions
Fierce Pharma
Thu, 06/1/23 - 06:41 pm
Biohaven
Pfizer
migraines
NICE
Nurtec
Vydura
With skin in the game, Satsuma's partner offers buyout to get migraine spray to market
Fierce Biotech
Mon, 04/17/23 - 12:07 pm
Satsuma Pharmaceuticals
Japan
migraines
Shin Nippon Biomedical
M&A

Pages